ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. scores highest on Anchor (71) and lowest on Price (0). Its PosiPenta is 46.78 out of 100, around the middle of similar companies.
On the Penta Grid this week, ADARx Pharmaceuticals, Inc. is Grid #344 of 837 in the Healthcare sector in United States, and Grid #2,239 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| ADARx Pharmaceuticals, Inc. | 46.78 | 0 | 46 | 61 | 56 | 71 |
| BioLife Solutions Inc | 58.21 | 30 | 47 | 97 | 74 | 44 |
| Astrana Health, Inc. | 62.30 | 38 | 88 | 75 | 47 | 64 |
| Establishment Labs Holdings Inc. | 38.04 | 1 | 62 | 58 | 10 | 59 |
| DENTSPLY SIRONA Inc. | 43.90 | 36 | 57 | 42 | 35 | 49 |
| Mineralys Therapeutics, Inc. | 34.22 | 20 | 34 | 26 | 39 | 52 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -15.22 |
| P/B ratio | -7.51 |
EEarnings
| Trailing EPS | ₹-109.87 |
| Forward EPS | — |
NNitro
| Price | 1671.72 |
| 52-week high | 2198.33 |
| 52-week low | 1576.06 |
| Fall from 52-week high | 24.0% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.06 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹17,854 Cr |
| Insider holding | 41.78% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is ADARx Pharmaceuticals, Inc.'s PosiPenta score?
ADARx Pharmaceuticals, Inc.'s PosiPenta is 46.78 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does ADARx Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, ADARx Pharmaceuticals, Inc. is Grid #344 of 837 in the Healthcare sector in United States, and Grid #2,239 of 4,000 in United States.
Which PosiPenta pillar is strongest for ADARx Pharmaceuticals, Inc.?
Anchor (stability and dividends), with a score of 71 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for ADARx Pharmaceuticals, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.